Invenomic Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Invenomic Capital Management’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,188,759	Closed	-$3.69M	–	195
2021 Q4	$3.69M	Buy	+1,188,759	New	+$4M	0.79%	46

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

Invenomic Capital Management's BDSI Position: Q1 2022 in Review

Invenomic Capital Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 1,188,759 shares — an estimated $3.69M sold.

Invenomic Capital Management first reported a position in BDSI in Q4 2021 and held it in 1 quarter. The position peaked at $3.69M in Q4 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

Invenomic Capital Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
Invenomic Capital Management sold 1,188,759 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $3.69M.
Invenomic Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q4 2021 and held it in 1 quarter.
Invenomic Capital Management's BioDelivery Sciences International, Inc. position peaked at $3.69M in Q4 2021.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Invenomic Capital Management's 13F filing for Q1 2022, filed 16 May 2022.